OXB Capital Markets Event
Oxford Biomedica (LON:OXB) Shares Pass Below 200 Day Moving Average – What’s Next?
OXB launches fast-track offering for AAV and lentiviral vector platforms, accelerating viral vector development and manufacture
Oxford Biomedica (LON:OXB) Stock Crosses Below 200 Day Moving Average – Here’s Why
Oxford Biomedica H2 Earnings Call Highlights
OXB recognised as ‘Most Innovative CDMO (Cell & Gene)’ at 2026 CDMO Leadership Awards
Preliminary results for the year ended 31 December 2025
Oxford Biomedica (LON:OXB) Stock Price Passes Below 200-Day Moving Average – Here’s What Happened
Oxford Biomedica (LON:OXB) Shares Pass Below 200 Day Moving Average – Should You Sell?
OXB announces date for Capital Markets Day and participation in upcoming investor conferences
Full year Trading Update and Notice of Results